These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33720432)

  • 41. [A case with a novel weak D type].
    He Y; Yu L; Xu D; Guo W; Deng G
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Jul; 36(7):731-733. PubMed ID: 31302923
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel laboratory technique demonstrating the influences of RHD zygosity and the RhCcEe phenotype on erythrocyte D antigen expression.
    McGann PT; Despotovic JM; Howard TA; Ware RE
    Am J Hematol; 2012 Mar; 87(3):266-71. PubMed ID: 22121029
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype.
    Sandler SG; Chen LN; Flegel WA
    Br J Haematol; 2017 Oct; 179(1):10-19. PubMed ID: 28508413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RhD alloimmunization without apparent exposure to RhD antigen.
    Kudva GC; Branson KD; Grossman BJ
    Am J Hematol; 2006 Mar; 81(3):218. PubMed ID: 16493600
    [No Abstract]   [Full Text] [Related]  

  • 45. [Identification of Phenotype and Genotype in One Case with Weak D blood group].
    Xu HY; Wang R; Lin CY; Yu SF; Liu CH; Tao ZH; Liao ZP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Dec; 26(6):1800-1803. PubMed ID: 30501723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Molecular mechanisms underlying DEL phenotype among ethnic Han individuals from Jiangsu].
    Chen Q; Wang S; Xiao J; Li P; Huang C; Yao G
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Apr; 33(2):240-3. PubMed ID: 27060325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A D+ blood donor with a novel RHD*D-CE(5-6)-D gene variant exhibits the low-frequency antigen RH23 (D(W) ) characteristic of the partial DVa phenotype.
    Lopez GH; McGowan EC; McGrath KA; Abaca-Cleopas ME; Schoeman EM; Millard GM; O'Brien H; Liew YW; Flower RL; Hyland CA
    Transfusion; 2016 Sep; 56(9):2322-30. PubMed ID: 27390888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transfusion support for a woman with
    Srivastava K; Bueno MU; Flegel WA
    Immunohematology; 2022 Apr; 38(1):17-24. PubMed ID: 35852060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Analysis of frequency of a RHD1227A allele in Chinese Hans].
    Wu X; Wu D; Wang M; Shao C; Xu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Dec; 31(6):793-6. PubMed ID: 25449092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How do I manage Rh typing in obstetric patients?
    Haspel RL; Westhoff CM
    Transfusion; 2015 Mar; 55(3):470-4. PubMed ID: 25647404
    [No Abstract]   [Full Text] [Related]  

  • 51. Small deletions within the RHD coding sequence: a report of two novel mutational events and a survey of the underlying pathophysiologic mechanisms.
    Chen JM; Fichou Y; Jamet D; Dupont I; Cooper DN; Le Maréchal C; Férec C
    Transfusion; 2013 Jan; 53(1):206-10. PubMed ID: 22612274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Three molecular structures cause rhesus D category VI phenotypes with distinct immunohematologic features.
    Wagner FF; Gassner C; Muller TH; Schonitzer D; Schunter F; Flegel WA
    Blood; 1998 Mar; 91(6):2157-68. PubMed ID: 9490704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RHD genotyping is recommended for all patients with serological weak-D phenotypes in Asian populations - Cases with coexistence of weak-D and Asia type DEL alleles results in complete expression of D-antigen.
    Chun S; Kim H; Yun JW; Yu H; Seo JY; Cho D
    Transfus Apher Sci; 2020 Aug; 59(4):102807. PubMed ID: 32423605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Investigation of the characteristics of Rh blood group of Uygur nationality in Xinjiang].
    Lan JC; Zhou HY; Bai XH; Chen XP; Xing YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):885-7. PubMed ID: 17708826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.
    Sandler SG; Flegel WA; Westhoff CM; Denomme GA; Delaney M; Keller MA; Johnson ST; Katz L; Queenan JT; Vassallo RR; Simon CD;
    Transfusion; 2015 Mar; 55(3):680-9. PubMed ID: 25438646
    [No Abstract]   [Full Text] [Related]  

  • 56. Two examples of an inseparable antibody that reacts equally well with DW+ and Rh32+ red blood cells.
    Reid ME; Sausais L; Zaroulis CG; Mohandas K; Coghlan G; Lomas-Francis C
    Vox Sang; 1998; 75(3):230-3. PubMed ID: 9852412
    [TBL] [Abstract][Full Text] [Related]  

  • 57. More on the R0 Har antigenic complex.
    Case J
    Transfusion; 1996; 36(11-12):1034-5. PubMed ID: 8937417
    [No Abstract]   [Full Text] [Related]  

  • 58. Secondary anti-D immunization by Del red blood cells.
    Yasuda H; Ohto H; Sakuma S; Ishikawa Y
    Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Phenotype Types and Genetic Mutation Mechanism of Rhesus D Variant Individuals].
    Luo H; Wen JZ; Zhang RQ; Ji YL; Mo CY; Wei L; Wang Z; Liao ZJ; Luo GP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1804-1809. PubMed ID: 29262920
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new RhD variant allele is caused by a RhD 26 T > G mutation in a Chinese Han woman with a weak D phenotype.
    Qian C; Li Q; Yuan C; Bao Y; Yu S; Li S; Wang Y; Tao Z; Zhong J
    Transfusion; 2019 Apr; 59(4):1400-1401. PubMed ID: 30659614
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.